One of the unique features of the DIA 2012 Annual Meeting is the Global Regulatory Track that includes 15 program offerings led by a variety of global and regional regulatory agencies including, FDA, EMA, Health Canada, SFDA-China, PMDA and more.

At the conclusion of this meeting, participants should be able to:
• Discuss key initiatives, changes, and challenges of various global regulatory agencies with the review of drugs, diagnostics/devices, and biologics

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.